Found 49 matching trials
Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs PHASE2 The primary objective of this trial is to investigate whether intramuscular...
Show More Location
University Medical Center Utrecht
Learn More & Join Trial
A Study of Human Allogeneic Bone-marrow-derived Mesenchymal Stromal Cell Product (StromaForte) in Patients With Aging Frailty PHASE1 The goal of this phase I/II clinical trial is to evaluate the safety and to...
Show More Learn More & Join Trial
3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects PHASE1 This study investigates safety and efficacy of traumatic bone defects treat...
Show More Location
LIMITED LIABILITY COMPANY "A.A. PARTNERS" (Medical company ilaya®)
Learn More & Join Trial
Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI) PHASE1 This is a Phase 1/2 study to determine the safety and efficacy of allogenei...
Show More Location
Multiple Locations
Learn More & Join Trial
Allogeneic MSC Treatment for Pulmonary Emphysema PHASE2 Rationale: Pulmonary emphysema is a component of Chronic Obstructive Pulmon...
Show More Location
Department of Pulmonology, Leiden University Medical Center
Learn More & Join Trial
An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis PHASE2 StromaForte injection for knee OA...
Location
Burjeel Medical City
Learn More & Join Trial
Cellular Immunotherapy for Septic Shock: A Phase I Trial PHASE1 This is a Phase I open label dose escalation trial of human allogeneic bone...
Show More Location
The Ottawa Hospital
Learn More & Join Trial
Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia PHASE1 Patients in the severe stages of Chronic limb-threatening ischemia (CLTI) a...
Show More Location
Fundación Oftalmológica de Santander (FOSCAL)
Learn More & Join Trial
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs PHASE2 This is a single-institution, phase II study to determine the event-free su...
Show More Location
University of Minnesota Masonic Cancer Center and Medical Center
Learn More & Join Trial
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines PHASE1 This randomized pilot phase I trial studies the side effects of donor bone ...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial